BACE1 and early-onset autosomal dominant Alzheimer disease: β-Secretase (β-site APP cleaving enzyme, BACE) is the rate limiting enzymatic activity in the production of the amyloid-β peptide (Aβ) and is thought to be involved in Alzheimer's disease (AD) pathogenesis [39].